Shenzhen BinDeBio Ltd.
6 clinical trials · Sponsor
◉ Watch Shenzhen BinDeBio Ltd.
| Record | Firm | Date |
|---|---|---|
| A Clinical Study of CAR-T Cells Treatment for Children With CD19+/CD22+ R/R ALL and Lymphoma (NCT04204161) | Shenzhen BinDeBio Ltd. | 2019-10-08 |
| Autologous CAR-T/TCR-T Cell Immunotherapy for Solid Malignancies (NCT03941626) | Shenzhen BinDeBio Ltd. | 2019-09-01 |
| Study of Autologous T-cells in Patients With Metastatic Pancreatic Cancer (NCT03638193) | Shenzhen BinDeBio Ltd. | 2018-07-11 |
| Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies (NCT03638206) | Shenzhen BinDeBio Ltd. | 2018-03-01 |
Track Shenzhen BinDeBio Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.